These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 348417)
1. The responses of Escherichia coli to nalidixic acid. Greenwood D; O'Grady F Chemotherapy; 1978; 24(4):249-58. PubMed ID: 348417 [No Abstract] [Full Text] [Related]
2. Rifampicin plus nalidixic acid: a rational combination for the treatment of urinary infection. Greenwood D; Andrew J J Antimicrob Chemother; 1978 Nov; 4(6):533-8. PubMed ID: 101503 [No Abstract] [Full Text] [Related]
3. Factors governing the emergence of resistance to nalidixic acid in treatment of urinary tract infection. Greenwood D; O'Grady F Antimicrob Agents Chemother; 1977 Dec; 12(6):678-81. PubMed ID: 337890 [TBL] [Abstract][Full Text] [Related]
4. [Study of nalidixic acid activity on 3186 strains of Gram negative bacilli. Application to the treatment of urinary infections]. Chamfeuil R; Curcier H Presse Med (1893); 1969 Nov; 77(48):1763-4. PubMed ID: 4903534 [No Abstract] [Full Text] [Related]
5. Norfloxacin: activity against urinary tract pathogens and factors influencing the emergence of resistance. Greenwood D; Osman M; Goodwin J; Cowlishaw WA; Slack R J Antimicrob Chemother; 1984 Apr; 13(4):315-23. PubMed ID: 6233248 [TBL] [Abstract][Full Text] [Related]
6. Differentiation of mechanisms responsible for inoculum effects in the response of Escherichia coli to a variety of antibiotics. Greenwood D J Antimicrob Chemother; 1976 Mar; 2(1):87-95. PubMed ID: 6416 [No Abstract] [Full Text] [Related]
11. The antibiotic sensitivity of 100 isolates of Escherichia coli, with special reference to the domiciliary treatment of urinary tract infections. Anderson K Med J Aust; 1970 Aug; 2(9):409-11. PubMed ID: 4924022 [No Abstract] [Full Text] [Related]
12. Nalidixic acid in urinary infection. Neogy KN; De MS; Chatterjee ML Bull Calcutta Sch Trop Med; 1968 Jan; 16(1):11-2. PubMed ID: 4890385 [No Abstract] [Full Text] [Related]
13. [Resistance to nalidixic acid in tetracycline-resistant mutants of E. coli]. Khanina MF; Gromova TG; Terekhov AA Antibiotiki; 1975; 20(12):1099-104. PubMed ID: 773284 [TBL] [Abstract][Full Text] [Related]
14. [Character of the effect of nalidixic acid (negram) on Escherichia coli strain 613]. Planel'es KhKh; Andreeva AM; Moroz AF Antibiotiki; 1968 Jul; 13(7):617-20. PubMed ID: 4880236 [No Abstract] [Full Text] [Related]
16. Observations on bacterial sensitivities to nalidixic acid and critical comments on the 6-centre survey. Brumfitt W; Pursell R Postgrad Med J; 1971 Sep; 47():Suppl:16-8. PubMed ID: 4939411 [No Abstract] [Full Text] [Related]
17. The effect of R-factor plasmids on host-cell responses to nalidixic acid I. Increased susceptibility of nalidixic acid-sensitive hosts. Crumplin GC; Smith JT J Antimicrob Chemother; 1981 Apr; 7(4):379-88. PubMed ID: 7019186 [No Abstract] [Full Text] [Related]
18. The clinical use of nalidixic acid. A review and some observations. Stamey TA; Nemoy NJ; Higgins M Invest Urol; 1969 May; 6(6):582-92. PubMed ID: 4976942 [No Abstract] [Full Text] [Related]
19. Are quinolone-resistant uropathogenic Escherichia coli less virulent? Vila J; Simon K; Ruiz J; Horcajada JP; Velasco M; Barranco M; Moreno A; Mensa J J Infect Dis; 2002 Oct; 186(7):1039-42. PubMed ID: 12232848 [TBL] [Abstract][Full Text] [Related]